Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #101 to #150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎CNS leukemia ‎[49,400 bytes]
  2. (hist) ‎Neuroendocrine tumor ‎[47,524 bytes]
  3. (hist) ‎Melanoma - null regimens ‎[46,771 bytes]
  4. (hist) ‎Pembrolizumab (Keytruda) ‎[46,169 bytes]
  5. (hist) ‎Gastric cancer, HER2-positive ‎[45,088 bytes]
  6. (hist) ‎COVID-19 coronavirus and cancer ‎[44,604 bytes]
  7. (hist) ‎B-cell acute lymphoblastic leukemia, pediatric - historical ‎[44,421 bytes]
  8. (hist) ‎COVID-19 coronavirus medical center experiences ‎[42,776 bytes]
  9. (hist) ‎Ovarian cancer - null regimens ‎[41,467 bytes]
  10. (hist) ‎Transformed lymphoma ‎[41,267 bytes]
  11. (hist) ‎Breast cancer, BRCA-mutated ‎[40,716 bytes]
  12. (hist) ‎Colon cancer - historical ‎[40,197 bytes]
  13. (hist) ‎Editing test page ‎[40,118 bytes]
  14. (hist) ‎Pancreatic NET ‎[39,904 bytes]
  15. (hist) ‎Antiemesis ‎[38,867 bytes]
  16. (hist) ‎Ovarian cancer, HRD-positive ‎[38,769 bytes]
  17. (hist) ‎Polycythemia vera ‎[38,550 bytes]
  18. (hist) ‎Myelofibrosis ‎[38,540 bytes]
  19. (hist) ‎Medulloblastoma ‎[38,032 bytes]
  20. (hist) ‎Primary mediastinal B-cell lymphoma ‎[37,359 bytes]
  21. (hist) ‎Breast cancer, HER2-positive - historical ‎[37,080 bytes]
  22. (hist) ‎Medulloblastoma - historical ‎[36,857 bytes]
  23. (hist) ‎Breast cancer - null regimens ‎[36,695 bytes]
  24. (hist) ‎Anal cancer ‎[36,358 bytes]
  25. (hist) ‎Leiomyosarcoma ‎[36,222 bytes]
  26. (hist) ‎Hairy cell leukemia ‎[36,133 bytes]
  27. (hist) ‎Prostate cancer - null regimens ‎[35,745 bytes]
  28. (hist) ‎Colorectal cancer - null regimens ‎[34,824 bytes]
  29. (hist) ‎Aplastic anemia ‎[33,233 bytes]
  30. (hist) ‎Colorectal cancer, MSI-H or dMMR ‎[33,141 bytes]
  31. (hist) ‎Anaplastic large cell lymphoma ‎[32,510 bytes]
  32. (hist) ‎Hepatocellular carcinoma - null regimens ‎[32,230 bytes]
  33. (hist) ‎Carcinoma of unknown primary ‎[31,941 bytes]
  34. (hist) ‎Hepatoblastoma ‎[31,841 bytes]
  35. (hist) ‎Urothelial carcinoma - historical ‎[31,700 bytes]
  36. (hist) ‎Osteosarcoma - historical ‎[31,257 bytes]
  37. (hist) ‎Thyroid cancer, differentiated ‎[30,870 bytes]
  38. (hist) ‎Ewing sarcoma, pediatric - historical ‎[30,566 bytes]
  39. (hist) ‎Gastric cancer - null regimens ‎[30,505 bytes]
  40. (hist) ‎Breast cancer, ER-positive - null regimens ‎[30,188 bytes]
  41. (hist) ‎Immunotherapy toxicity management ‎[30,081 bytes]
  42. (hist) ‎Main Page ‎[30,016 bytes]
  43. (hist) ‎Editorial Board ‎[29,960 bytes]
  44. (hist) ‎Kaposi sarcoma ‎[29,261 bytes]
  45. (hist) ‎Multiple myeloma - null regimens ‎[29,117 bytes]
  46. (hist) ‎Stem cell mobilization regimens ‎[29,100 bytes]
  47. (hist) ‎Hodgkin lymphoma, nodular lymphocyte-predominant ‎[28,856 bytes]
  48. (hist) ‎Editorial board transclusions ‎[28,854 bytes]
  49. (hist) ‎Mantle cell lymphoma - historical ‎[28,273 bytes]
  50. (hist) ‎Prostate cancer, BRCA-mutated ‎[27,832 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)